Bharat Biotech’s nasal booster gets nod for trials

Bharat Biotech has received the Drugs Controller General of India (DCGI)’s permission for conducting Phase-III clinical trials of its intranasal Covid-19 vaccine BBV154 as a booster for other vaccines.

from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://bit.ly/3uboige